retatrutide mechanism triple agonist glp-1 gip glucagon Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research retatrutide mechanism of action triple
Description
De Boer SY, Masclee AA, Lam WF, Lamers CB
doi:10.1001/jamanetworkopen.2025.21016 2
Significant weight loss usually develops gradually over several months of consistent treatment
Among GLP-1RAs, Semaglutide was the most cost-effective obesity medication [59] [60]
Severe but Rare Complications of GLP-1 and Peptide Therapy Pancreatitis and Gallbladder Problems Some studies suggest a link between GLP-1 therapies and acute pancreatitis or gallstones
Semaglutide is also under clinical trials for NASH, Alzheimers disease
